References:
- Olsen L, Sparsø T, Weinsheimer SM, et al. Prevalence of rearrangements
in the 22q11.2 region and population-based risk of neuropsychiatric
and developmental disorders in a Danish population: a case-cohort
study. Lancet Psychiatry 2018;5 :573-80.
- Fung WL, Butcher NJ, Costain G, et al. Practical guidelines for
managing adults with 22q11.2 deletion syndrome. Genet Med
2015;17 :599-609.
- Habel A, Herriot R, Kumararatne D, et al. Towards a safety net for
management of 22q11.2 deletion syndrome: guidelines for our times. Eur
J Pediatr.
2014;173 :757-65.
- Kobrynski LJ, Sullivan KE. Velocardiofacial syndrome, DiGeorge
syndrome: the chromosome 22q11.2 deletion syndromes. Lancet
2007;370 :1443-52.
- Unolt M, Versacci P, Anaclerio S, et al. Congenital heart diseases and
cardiovascular abnormalities in 22q11.2 deletion syndrome: From
well-established knowledge to new frontiers. Am J Med Genet A
2018;176 :2087-98.
- Karayiorgou M, Simon TJ, Gogos JA. 22q11.2 microdeletions: linking DNA
structural variation to brain dysfunction and schizophrenia. Nat Rev
Neurosci 2010;11 :402-16.
- Constance LSL, Lansing MG, Khor FK, et al. Schizophrenia and
anaesthesia. BMJ Case Rep 2017;23 :bcr2017221659.
- AlQarni MA, Alharbi A, Merdad L. Dental management of a patient with
22q11.2 deletion syndrome (22q11.2DS). BMJ Case Rep
2018;18 :bcr2018225765.